Health Care · Health Care Facilities · US stock · price as of 16 Oct 2026
Key indicators
Price
$185.10
52-week range
$139.92 – $245.26
Market cap
$11.1B
P/E (trailing)
7.6×
EV / EBITDA
5.9×
Free-cash-flow yield
7.6%
Dividend yield
0.4%
Revenue (last 12 months)
$18.1B
Revenue growth (3y a year)
9.0%
Operating margin
11.4%
Return on invested capital
12.9%
Net debt / EBITDA
1.7×
Fair value
Blended fair value$761.43 range $709 – $826
Versus priceData under review+0% to fair value
Peer multiples
$689.66
Fundamentals-adjusted multiple
$797.24
10-year DCF (market-scaled)
$797.38
Earnings power value (floor, not blended)
$237.73
Model uncertainty
Medium
X-Ray Score
66/ 100 · Medium confidence · ahead of 85% of sector peers
Valuation94
Growth76
Profitability45
Financial health63
Dividends31
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Universal Health Services operates hospitals and care facilities. Its acute care hospitals are located in the United States, and it runs a large behavioral health business with inpatient psychiatric hospitals and treatment centers in the United States and United Kingdom. Revenue comes from patient services paid by government programs, commercial insurers and individuals, so reimbursement rates and patient volumes matter.
Universal Health Services Inc generated $18.1 billion in revenue during the last twelve months. The three-year revenue growth rate is 9.0% a year. Operating margin stands at 11.4%, showing profit left after running costs. Return on invested capital stands at 13%. Net debt is 1.7 times of EBITDA. A dividend is paid, with a yield of 0.4%.
StocksXray gives Universal Health Services Inc an X-Ray Score of 66 out of 100 (medium confidence), ahead of 85% of the S&P 500 stocks in its sector. Its strongest lens is valuation (94) and its weakest is dividends (31).
Our fair value blend is $761.43 (range $708.57 to $825.57). At $185.10 the stock trades 76% below that blend, so the label is "Data under review" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Universal Health Services Inc (UHS)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$126.57
$138.43
$150.66
$178.05
$217.25
$185.10
Market cap
$10.6B
$10.2B
$10.6B
$12.1B
$14.0B
$11.1B
P/E
10.7×
15.1×
14.7×
10.6×
9.4×
7.6×
EV / revenue
1.2×
1.1×
1.1×
1.0×
1.1×
0.9×
EV / EBITDA
7.8×
9.4×
8.8×
7.3×
7.2×
5.9×
Price / free cash flow
377.8×
39.0×
20.1×
10.8×
16.5×
13.1×
Free-cash-flow yield
0.3%
2.6%
5.0%
9.3%
6.1%
7.6%
Price / book
1.7×
1.7×
1.7×
1.8×
1.9×
1.5×
Dividend yield
0.63%
0.58%
0.53%
0.45%
0.37%
0.43%
Fundamentals checklist ● 8 Good · ● 3 Average · ● 3 Bad · each check graded against the sector
Cash quality
Earnings backed by cash−1.7%Bad
Free-cash-flow yield7.6%Good
Risk models
Piotroski F-Score8 of 9Good
Growth
EPS growth (3y)36.2%Good
Free-cash-flow growth (3y)48.0%Good
Revenue growth (3y)9.0%Good
Growth consistency100%Good
Balance sheet
Current ratio1.1×Bad
Net debt / EBITDA1.7×Average
Interest cover13.1×Average
Valuation
Fair value vs price4.1×Good
EBIT / EV yield13.0%Good
Profitability
Return on invested capital12.9%Average
Operating margin11.4%Bad
XStocksXray
Universal Health Services Inc (UHS)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
12,642
13,399
14,282
15,828
17,365
18,114
Gross profit
–
–
–
–
–
–
Operating income
1,363
1,004
1,175
1,682
1,994
2,058
Net income
992
676
718
1,142
1,489
1,526
Diluted EPS ($)
11.82
9.14
10.23
16.82
23.10
24.45
Free cash flow
28
262
525
1,123
849
845
Gross margin
–
–
–
–
–
–
Operating margin
10.8%
7.5%
8.2%
10.6%
11.5%
11.4%
Net margin
7.8%
5.0%
5.0%
7.2%
8.6%
8.4%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
13,094
13,494
13,968
14,470
15,528
15,935
Cash
115
103
119
126
138
139
Total debt
4,190
4,808
4,912
4,505
4,753
4,852
Equity
6,090
5,921
6,149
6,666
7,276
7,514
Dividend per share ($)
0.80
0.80
0.80
0.80
0.80
0.80
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.